In today's health-conscious world, keeping track of one's glucose levels is more important than ever. With various sugar test kits available on the market, selecting the right brand can make a significant difference in the accuracy and ease of monitoring your blood sugar levels. Leading brands offer advanced technology, user-friendly designs, and reliable results, ensuring that managing diabetes or simply keeping tabs on your health is a straightforward process. Explore our comprehensive guide below to discover the best brands for sugar test kits that cater to your needs.
Illustration of sugar test kit
Best brands of sugar test kit in 2025
Accu-Chek
Accu-Chek, a leading brand in the diabetes management sector, has established itself as a top producer of sugar test kits, particularly with the Accu-Chek Inform II, which held a significant market share of 18.9% to 19% in 2023. This product is renowned for its accuracy in measuring blood glucose levels across various sample types, including venous, capillary, whole blood, neonatal, and arterial samples. The Accu-Chek Guide 100 test strips are also highly regarded for their reliability, requiring only a 0.6 microliter blood sample and providing results in just a few seconds. The brand's advanced technology, such as the SmartPack feature and Bluetooth connectivity with the mySugr app, enhances user convenience and data management. The U.S. point-of-care glucose testing market, dominated by Accu-Chek products, is projected to grow at a CAGR of 4.6% from 2024 to 2033.
OneTouch
The OneTouch brand is renowned for its high-quality glucose testing kits, particularly the OneTouch Verio Flex, which has been rated as one of the best standard glucose meters in 2022 by Forbes Health. This meter stands out for its ColorSure(r) technology, affordable test strips, and compact design, requiring only a small sample of blood. It is part of the U.S. point-of-care glucose testing market, which accounted for over 34% of the global market share in 2023 and is expected to grow at a CAGR of 4.5% from 2024 to 2030. The OneTouch Verio Flex meter is highly recommended for its ease of use and accuracy, making it a favorite among diabetes patients. Its integration with the OneTouch Reveal mobile app further enhances diabetes management.
FreeStyle
The FreeStyle brand, owned by Abbott, is a leading producer of sugar test kits, renowned for its innovative and user-friendly products. The FreeStyle Lite meter, for instance, is expected to witness the fastest growth rate in the point-of-care glucose testing market, thanks to its discreet size and in-built portlight and backlight, making it ideal for busy lifestyles. Abbott's FreeStyle Libre systems, used by over 6 million people globally, have been instrumental in improving glucose control, lowering HbA1c levels, and reducing diabetes-related hospital admissions. The company has recently received FDA clearance for two new over-the-counter continuous glucose monitoring systems, Lingo and Libre Rio, further expanding its portfolio. With a robust sales increase, led by the FreeStyle Libre, Abbott continues to dominate the market.
Contour Next
The Contour Next brand, managed by Ascensia Diabetes Care, is renowned for its high-quality blood glucose test kits, offering remarkably accurate results with a precision of up to 99.7% accuracy in blood glucose measurements. The Contour Next ONE meter, for instance, features advanced technologies such as Smartlight(tm) for instant feedback on blood glucose levels and Second-Chance(r) Sampling to reduce wasted strips. These innovations make it a preferred choice for diabetes management, with the brand consistently passing rigorous accuracy tests. The Contour Next series is also known for its ease of use and compatibility with various diabetes management software and apps. This brand's commitment to accuracy and user convenience has made it a leader in the blood glucose test strip market.
True Metrix
The True Metrix brand, developed by Nipro Diagnostics, is renowned for its high-accuracy blood glucose monitoring systems, exceeding the stringent ISO 15197:2013 performance requirements. Featuring TRIPLE SENSE TECHNOLOGY™, these meters detect, analyze, and correct for environmental and physiological variability, ensuring precise results. The system allows for fast testing, with results in as little as 4 seconds, and requires a tiny 0.5 microliter blood sample. True Metrix meters also offer advanced features such as event tagging, 7-, 14-, and 30-day averaging, and downloadable data capabilities. Since its FDA clearance in 2014, True Metrix has been a valued addition to the diabetes management ecosystem. For more information, visit their True Metrix products page.
CareSens
CareSens is a leading brand in the glucose testing market, known for its advanced and user-friendly products. The CareSens Expert Plus segment is expected to grow at the fastest CAGR of 9.1% over the forecast period, driven by its features such as automatic strip recognition and seamless real-time data transfer via various connectivity options. The CareSens N Plus Bluetooth Blood Glucose Monitor requires only a small blood sample size of 0.5 mL and provides fast results in just 5 seconds, making it a convenient and painless option for blood sugar testing. This product also integrates with a mobile app, enhancing the user experience and facilitating better diabetes management. With its dedicated customer service and comprehensive starter kit, CareSens stands out as a reliable choice for diabetes testing.
ForaCare
ForaCare is recognized as a leading producer of sugar test kits, known for its high-quality and accurate blood glucose monitoring systems. The company's products are widely used by individuals with diabetes, particularly those with type 1 and type 2 diabetes, which accounted for over 92.7% of the diabetic population in 2023. ForaCare's test strips and glucometers are designed to ensure precise readings, contributing to the growing demand in the global blood glucose test strips market, which is projected to reach $21.16 billion by 2030 with a CAGR of 6.2%. The company's commitment to innovation and customer satisfaction has made it a trusted name in the point-of-care glucose testing market, which is expected to attain $5.50 billion by 2034. ForaCare's products are available globally, with a significant presence in regions like North America and Asia Pacific.
Prodigy
Prodigy Diabetes Care is a leading producer of sugar test kits, notably gaining significant market share in the Medicare mail-order market. By 2013, the Prodigy Autocode accounted for 26.9% of the market share, a substantial increase from 2.4% in 2009. The company's focus on lean, efficient business operations and in-house manufacturing enables it to produce high-quality products at a lower cost, making it competitive against traditional big players like Lifescan, Roche, Bayer, and Abbott. Prodigy's products are part of the top 10 strip types that account for 98% of the Medicare mail-order market. The company's presence in North America, a region dominating the global point-of-care glucose testing market, further solidifies its position. For more details, visit their pressroom.
Dario
The Dario Blood Glucose Monitoring System, developed by LabStyle Innovations, is a highly accurate and user-friendly device for monitoring blood glucose levels, particularly for people with type 1 and type 2 diabetes. It boasts over 99% accuracy, meeting and exceeding ISO 2013 performance requirements, with 95% of measured values within +-15% and 99% within +-20% of the true value. The system integrates seamlessly with smartphones, both iOS and Android, and includes a built-in lancet and storage for 25 test strips. Approved by the FDA in 2018, the Dario meter has received positive feedback, with an average rating of 3.8 stars on Google and 4.4 stars on Amazon. Its precision and reliability make it a standout in the market for blood glucose monitoring. For more insights, you can read about the Dario Glucose Meter.
Abbott Diabetes Care
Abbott's Diabetes Care brand, particularly its Freestyle Libre continuous glucose monitors, has established itself as a leading producer in the sugar test kit market. In 2022, the Freestyle Libre generated $4.3 billion in sales, a 22% increase year over year, and the company aims to reach $10 billion in sales by 2028 with a projected 15% annual growth rate. With over 4.5 million users, Abbott's CGMs bring in significant revenue, and the company is expanding its customer base to include more people with Type 2 diabetes and those using basal insulin. The integration of its sensors with insulin pumps, such as Tandem Diabetes Care's t:slim X2 pump, and the development of a dual analyte sensor are key strategies for growth. Additionally, Abbott's direct-to-consumer program, Lingo, aims to expand the use of its technology beyond diabetes to general health and wellness.
Leave a Reply
Your email address will not be published.